TCL Archive FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity. September 29, 2000
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
